Eversana, China Resource Pharmaceutical Commercial Group Announce Global Partnership
Alliance aims to expand access to innovative healthcare solutions.
Eversana, a global services provider for the life science industry, is establishing a strategic partnership with the China Resources Pharmaceutical Commercial Group, a pharmaceutical distribution enterprise. As part of the union, the two organizations are expected to collaborate on expanding healthcare solutions both nationally and outside of China to ultimately discover new treatment options for a variety of diseases.
"We know that to make the biggest impact in the region and across the globe, we must find ways to break down existing barriers and bring innovative therapies both in and outside of China,” said Jim Lang, CEO, Eversana. “Through this alliance, we’ll work to establish a framework that can drive innovation, enhance patient care, and create transformative advancements for patients throughout the globe."
Reference: EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally. June 1, 2023/PR Newsire
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
